Grow Brian (CIK 1759142) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-04-24). Recent activity: Buy ORGO (958 shares), Buy ORGO (48,818 shares), Sell ORGO (11,887 shares), Buy ORGO (234,375 shares), Buy ORGO (48,330 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-24 | Organogenesis Holdings Inc. (ORGO) | Chief Commercial Officer | Buy | 958 | $1,188 |
| 2026-03-03 | Organogenesis Holdings Inc. (ORGO) | Chief Commercial Officer | Buy | 48,818 | $0 |
| 2026-03-03 | Organogenesis Holdings Inc. (ORGO) | Chief Commercial Officer | Sell | 11,887 | $45,646 |
| 2026-02-20 | Organogenesis Holdings Inc. (ORGO) | Chief Commercial Officer | Buy | 234,375 | $0 |
| 2026-02-20 | Organogenesis Holdings Inc. (ORGO) | Chief Commercial Officer | Buy | 48,330 | $0 |
| 2026-02-20 | Organogenesis Holdings Inc. (ORGO) | Chief Commercial Officer | Sell | 11,768 | $45,189 |
| 2026-02-18 | Organogenesis Holdings Inc. (ORGO) | Chief Commercial Officer | Sell | 3,346 | $12,481 |
| 2026-02-18 | Organogenesis Holdings Inc. (ORGO) | Chief Commercial Officer | Sell | 18,910 | $70,534 |
| 2026-02-18 | Organogenesis Holdings Inc. (ORGO) | Chief Commercial Officer | Sell | 10,559 | $39,385 |
| 2026-02-18 | Organogenesis Holdings Inc. (ORGO) | Chief Commercial Officer | Sell | 11,144 | $41,567 |
| 2025-08-13 | Organogenesis Holdings Inc. (ORGO) | Chief Commercial Officer | Buy | 4,060 | $10,028 |
| 2025-08-13 | Organogenesis Holdings Inc. (ORGO) | Chief Commercial Officer | Sell | 2,173 | $10,039 |
Source: SEC Form 4 filings · as of 2026-04-24